SCHEMBL18044684

SCHEMBL18044684

Nc1ncnc2c1c(-c1ccc(NC(=O)c3cc4c(n(-c5ccccc5)c3=O)CCCC4=O)cc1)cn2C1CC(COCc2ccccc2)C1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TYRO3 Q06418 1/20 0.49
▸ IGF1R P08069 9/20 0.48
▸ INSR P06213 5/20 0.48
▸ MERTK Q12866 4/20 0.47
▸ AXL P30530 2/20 0.47
▸ RET P07949 5/20 0.46
▸ LYN P07948 3/20 0.45
▸ SRC P12931 3/20 0.45
▸ LCK P06239 2/20 0.45
▸ KIT P10721 2/20 0.45
▸ FGFR1 P11362 2/20 0.45
▸ FLT1 P17948 2/20 0.45
▸ FLT4 P35916 2/20 0.45
▸ KDR P35968 2/20 0.45
▸ FLT3 P36888 2/20 0.45
▸ ERBB4 Q15303 2/20 0.45
▸ ACVR1 Q04771 2/20 0.45
▸ ROCK2 O75116 2/20 0.45
▸ PDPK1 O15530 1/20 0.45
▸ EGFR P00533 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18044681 1.00 TYRO3 (0.49) TYRO3IGF1RINSRMERTKAXL
SCHEMBL18044548 0.91 TYRO3 (0.53) TYRO3IGF1RINSRMERTKAXL
SCHEMBL18045153 0.85 AXL (0.60) TYRO3IGF1RINSRMERTKAXL
SCHEMBL18044653 0.85 TYRO3 (0.57) TYRO3INSRMERTKAXLRET
SCHEMBL16709454 0.82 TYRO3 (0.57) TYRO3MERTKAXLMETUSP2
SCHEMBL18044625 0.81 IGF1R (0.50) TYRO3IGF1RINSRMERTKAXL
SCHEMBL18044587 0.81 IGF1R (0.50) TYRO3IGF1RINSRMERTKAXL
SCHEMBL18044623 0.81 IGF1R (0.50) TYRO3IGF1RINSRMERTKAXL
SCHEMBL18044590 0.81 IGF1R (0.50) TYRO3IGF1RINSRMERTKAXL
SCHEMBL18044583 0.80 TYRO3 (0.55) TYRO3MERTKAXLMETUSP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3067356-B1 PYRROLO PYRIMIDINE DERIVATIVE ONO PHARMACEUTICAL CO (JP) 2018-07-04 — — EP disclosed
US-9586967-B2 Pyrrolo pyrimidine derivative ONO PHARMACEUTICAL CO., LTD. (JP) 2017-03-07 — — US disclosed
US-20160264579-A1 PYRROLO PYRIMIDINE DERIVATIVE ONO PHARMACEUTICAL CO., LTD. (JP) 2016-09-15 — — US disclosed
EP-3067356-A1 PYRROLO PYRIMIDINE DERIVATIVE ONO Pharmaceutical Co., Ltd. (JP) 2016-09-14 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160264579-A1 PYRROLO PYRIMIDINE DERIVATIVE AXL, FLT3, TYRO3 TYRO3 3/4885IGF1R 91/4885INSR 971/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback